Abstract:The present study provides important evidence that aging results in an increased abundance of endothelial cells with dysfunctional telomeres in humans and mice. Moreover, we demonstrate that genetic induction of telomere dysfunction specifically in endothelial cells results in cellular senescence and exacerbates multiple hallmarks of vascular and metabolic aging. In advanced age, increases in oxidative stress and inflammation impair endothelial function, which contributes to the development of cardiovascular disease (CVD). One plausible source of this oxidative stress and inflammation is an increase in the abundance of senescent endothelial cells. To test whether this results in senescence, we selectively reduced the telomere shelterin protein telomere repeat binding factor 2 (Trf2) from endothelial cells of young mice. Trf2 reduction increased endothelial cell telomere dysfunction and resulted in cellular senescence. Furthermore, induction of endothelial cell telomere dysfunction increased inflammatory signaling and oxidative stress, resulting in impairments in endothelial function. Finally, we demonstrate that endothelial cell telomere dysfunction‐induced senescence impairs glucose tolerance. This likely occurs through increases in inflammatory signaling in the liver and adipose tissue, as well as reductions in microvascular density and vasodilation to metabolic stimuli. Cumulatively, the findings of the present study identify age‐related telomere dysfunction as a mechanism that leads to endothelial cell senescence. Furthermore, these data provide compelling evidence that senescent endothelial cells contribute to age‐related increases in oxidative stress and inflammation that impair arterial and metabolic function.

The role of senescence, telomere dysfunction and shelterin in vascular aging

Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases

Endothelial cell telomere dysfunction induces senescence and results in vascular and metabolic impairments

Targeting vascular senescence in cardiovascular disease with aging

Endothelial Cell Senescence and Age-Related Vascular Diseases

Factors and Pathways Modulating Endothelial Cell Senescence in Vascular Aging

The protective role of Sirt1 in vascular tissue: its relationship to vascular aging and atherosclerosis

Understanding the Intricacies of Cellular Senescence in Atherosclerosis: Mechanisms and Therapeutic Implications

The mechanisms of vascular aging

Targeting senescent cells for vascular aging and related diseases

Age-Related Impairment Of Vascular Structure And Functions

Pro‐inflammatory cytokines mediating senescence of vascular endothelial cells in atherosclerosis

Vascular Aging in Ischemic Stroke.

The Role and Mechanism of Vascular Aging in Geriatric Vascular Diseases

Cellular Senescence in Cardiovascular Diseases: From Pathogenesis to Therapeutic Challenges

Vascular aging: Molecular mechanisms and potential treatments for vascular rejuvenation

The Role of Oxidative Stress and Inflammation in Cardiovascular Aging

Decoding vascular aging: implications for atherosclerosis progression and clinical intervention

Cellular Senescence and Vascular Disease: Novel Routes to Better Understanding and Therapy

Exercise Protects Vascular Function by Countering Senescent Cells in Older Adults

Hypoxia-Inducible Factor-1α: The Master Regulator of Endothelial Cell Senescence in Vascular Aging